American International Group, Inc. Amgen Inc Transaction History

American International Group, Inc.

$27.6 Billion
Q1 2024

A detailed history of American International Group, Inc. transactions in Amgen Inc stock. As of the latest transaction made, American International Group, Inc. holds 189,221 shares of AMGN stock, worth $59.1 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

189,221

Previous 190,691 0.77%

Holding current value

$59.1 Million

Previous $54.9 Million 2.04%

% of portfolio

0.19%

Previous 0.23%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $395,238 - $477,103	-1,470 Reduced 0.77%	189,221 $53.8 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $1.64 Million - $1.85 Million	-6,410 Reduced 3.25%	190,691 $54.9 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $1.19 Million - $1.48 Million	5,456 Added 2.85%	197,101 $53 Million
Q2 2023 Aug 04, 2023	BUY	$214.27 - $253.37 $510,176 - $603,273	2,381 Added 1.26%	191,645 $42.5 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $198,920 - $242,451	881 Added 0.47%	189,264 $45.8 Million

Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $2.29 Million - $2.91 Million	-10,011 Reduced 5.05%	188,383 $49.5 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $702,784 - $792,612	-3,131 Reduced 1.55%	198,394 $44.7 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $3.56 Million - $3.97 Million	-15,448 Reduced 7.12%	201,525 $49 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $1.53 Million - $1.69 Million	-6,984 Reduced 3.12%	216,973 $52.5 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $319,003 - $365,070	-1,604 Reduced 0.71%	223,957 $50.4 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $139 Million - $163 Million	-656,708 Reduced 74.43%	225,561 $48 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $14.4 Million - $16 Million	-61,688 Reduced 6.54%	882,269 $215 Million
Q1 2021 May 07, 2021	SELL	$221.91 - $258.6 $3.87 Million - $4.51 Million	-17,458 Reduced 1.82%	943,957 $235 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $13.5 Million - $16.1 Million	-62,357 Reduced 6.09%	961,415 $221 Million
Q3 2020 Nov 04, 2020	SELL	$234.65 - $260.95 $20.9 Million - $23.2 Million	-88,952 Reduced 7.99%	1,023,772 $260 Million
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $7.13 Million - $8.74 Million	-36,023 Reduced 3.14%	1,112,724 $262 Million
Q1 2020 May 04, 2020	BUY	$182.24 - $241.7 $158 Million - $210 Million	868,178 Added 309.43%	1,148,747 $233 Million
Q4 2019 Feb 05, 2020	BUY	$189.21 - $243.2 $826,090 - $1.06 Million	4,366 Added 1.58%	280,569 $67.6 Million
Q3 2019 Nov 08, 2019	SELL	$174.11 - $208.62 $1.04 Million - $1.24 Million	-5,960 Reduced 2.11%	276,203 $53.4 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $4.31 Million - $5.05 Million	-25,857 Reduced 8.39%	282,163 $52 Million
Q1 2019 May 06, 2019	SELL	$180.87 - $203.88 $3.81 Million - $4.3 Million	-21,069 Reduced 6.4%	308,020 $58.5 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $2.01 Million - $2.35 Million	-11,266 Reduced 3.31%	329,089 $64.1 Million
Q3 2018 Nov 09, 2018	BUY	$185.29 - $208.89 $1.31 Million - $1.47 Million	7,060 Added 2.12%	340,355 $70.6 Million
Q2 2018 Aug 08, 2018	SELL	$166.05 - $186.51 $816,467 - $917,069	-4,917 Reduced 1.45%	333,295 $61.5 Million
Q1 2018 May 07, 2018	BUY	$169.43 - $198.0 $257,364 - $300,762	1,519 Added 0.45%	338,212 $57.7 Million
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $486,283 - $543,327	2,881 Added 0.86%	336,693 $58.6 Million
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $55.8 Million - $63.8 Million	333,812	333,812 $62.2 Million

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account

American International Group, Inc. Amgen Inc Transaction History